Reuters logo
BRIEF-Regen Biopharma restructures management stock compensation
March 15, 2017 / 12:28 PM / 7 months ago

BRIEF-Regen Biopharma restructures management stock compensation

March 15 (Reuters) - Regen Biopharma Inc

* Regen Biopharma restructures management stock compensation

* Management team has agreed to collectively cancel 16.5 million common shares and 15 million series a preferred shares

* Company has created a new class of stock, series M preferred which does not trade publicly

* Management team will receive replacement shares for publicly traded shares they cancelled Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below